Eterna Therapeutics
ERNA
8 hedge funds and large institutions have $5.27M invested in Eterna Therapeutics in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
59% more capital invested
Capital invested by funds: $3.31M → $5.27M (+$1.96M)
11% less funds holding
Funds holding: 9 → 8 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$168K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$83.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $2.03M | – | – | – |
|
|
AIC
2
AWM Investment Company
New York
| $1.71M | -$168K | -2 | -11% |
|
|
EAM
3
Eagle Asset Management
St Petersburg,
Florida
| $489K | – | – | – |
|
4
Renaissance Technologies
New York
| $332K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $144K | – | – | – |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $144K | – | – | – |
|
|
BA
7
Bard Associates
Chicago,
Illinois
| $137K | – | – | – |
|
|
CA
8
Callahan Advisors
Houston,
Texas
| $128K | – | – | – |
|
9
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $102K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $22K | -$83.8K | -1 | Closed |
|
11
BlackRock
New York
| $20K | – | – | – |
|
|
KCPG
12
Kavar Capital Partners Group
Leawood,
Kansas
| $6K | – | – | – |
|
|
LTFS
13
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
ERNA Hedge Fund Activity: Q1 2018 in Review
8 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2018, worth a combined $5.27M — up 59% from $3.31M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ERNA and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was AWM Investment Company, cutting an estimated $168K.
- 8 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2018, down from 9 in Q4 2017.
- Funds reported $5.27M of Eterna Therapeutics stock for Q1 2018, up 59% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q1 2018 and 1 closed out, a net change of -1 holder.
- The largest Eterna Therapeutics seller in Q1 2018 was AWM Investment Company, an estimated $168K sold.
Based on aggregated 13F filings for Q1 2018.